Skip to main content
. 2020 Mar 17;11:136. doi: 10.3389/fendo.2020.00136

Figure 6.

Figure 6

miR-183-5p and miR-21 compromised the inhibitory effects of OTUD6B-AS1 on proliferation of thyroid carcinoma cells. (A,C) miR-183-5p or miR-21 expression were measured using qRT-PCR after transfection with miR-183-5p and miR-21 at 48 h in SW579 and TPC-1 cells (n = 3). ***p < 0.001, vs. Cells group; (B,D) miR-183-5p and miR-21 expression were measured using qRT-PCR after co-transfected OTUD6B-AS1 with miR-183-5p and (or) miR-21 at 48 h in SW579 and TPC-1 cells (n = 3). ***p < 0.001, vs. transfection OTUD6B-AS1 group; (E,F) MTT assays of thyroid carcinoma cells at 48 h after transfection. Data were presented as mean ± sd (n = 3). *p < 0.05, **p < 0.01, and ***p < 0.001, vs. Cells group; ##p < 0.05 and ###p < 0.001, vs. OTUD6B-AS1 group.